Veteran Oncologist and Cancer Center Leader Dr. Howard Bailey Joins Cofactor Genomics as Chief Medical Officer
AI Briefing
- • Cofactor Genomics appoints Dr. Howard H. Bailey, MD, as Chief Medical Officer.
- • Dr. Bailey is former Director of University of Wisconsin Carbone Cancer Center.
- • He brings 36 years of experience in oncology and cancer research to the role.
Source Summary
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced the appointment of Howard H. Bailey, MD, as Chief Medical Officer. Dr. Bailey is the former Director of the University of Wisconsin Carbone Cancer Center and an internationally recognized oncologist and cancer researcher whose 36-year career has spanned patient care, cancer-center leadership, building multi-institution research
Advertisement